Cleared Traditional

K213116 - Everyway Incontinence Stimulation System

K213116 is the FDA 510(k) clearance for Everyway Incontinence Stimulation System by Everyway Medical Instruments Co.,Ltd. It is a Class 2 Gastroenterology & Urology device (product code KPI) cleared through the Traditional 510(k) pathway after a 67-day FDA review.

K213116 · Everyway Medical Instruments Co.,Ltd · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2021
Decision
67d
Days
Class 2
Risk

K213116 is an FDA 510(k) clearance for the Everyway Incontinence Stimulation System. Classified as Stimulator, Electrical, Non-implantable, For Incontinence (product code KPI), Class II - Special Controls.

Submitted by Everyway Medical Instruments Co.,Ltd (Shenkeng District, New Taipei City, CN). The FDA issued a Cleared decision on December 3, 2021 after a review of 67 days - a notably fast clearance cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5320 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Everyway Medical Instruments Co.,Ltd devices

Submission Details

510(k) Number K213116 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 27, 2021
Decision Date December 03, 2021
Days to Decision 67 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
63d faster than avg
Panel avg: 130d · This submission: 67d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KPI Stimulator, Electrical, Non-implantable, For Incontinence
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.5320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - KPI Stimulator, Electrical, Non-implantable, For Incontinence

All 52
Devices cleared under the same product code (KPI) and FDA review panel - the closest regulatory comparables to K213116.
Well-Life Probe Electrode for Stimulation/EMG Probe (Model: SA), Well-Life Incontinence Stimulation/EMG Electrode Probe, Well-Life Probe Electrode
K222528 · Well-Life Healthcare Limited · Dec 2022
Biofeedback Nerve and Muscle Stimulator
K220161 · Shenzhen Konmed Technology Co., Ltd. · Jul 2022
Keffort (MC-100, MC-100A)
K213133 · Oriental Inspiration Limited · Apr 2022
Incontinence Probe
K210441 · Shenzhen Med-Link Electronics Tech Co., Ltd. · Sep 2021
MyOnyx System
K201014 · Thought Technology , Ltd. · Jan 2021
InMode System with vTone Applicator
K200293 · Inmode , Ltd. · May 2020